7 glucoside/inflammation

This application is a National Stage application of PCT international application PCT/EP2012/067584, filed on Sep. 7, 2012 which claims the priority of French Patent Application No. 11 57795 entitled "ANTI-INFLAMMATORY COMPOSITION", filed with the European Patent Office on Sep. 8, 2011, both of

TECHNICAL FIELD This invention relates to a novel preventive and curative agent for inflammatory bowel diseases. More particularly, this invention relates to a preventive and curative agent for inflammatory bowel diseases, using a water-soluble chromanol glucoside as an active ingredient. BACKGROUND

The invention relates to a fiber-enriched anti-inflammatory and/or analgesic composition for the bowel, characterized in that it comprises branched maltodextrins. Chronic inflammatory bowel diseases (or IBDs) include in particular two distinct conditions: ulcerative colitis (UC) and Crohn's disease.

FIELD OF THE INVENTION This invention relates to N-acylated glucosamine derivatives; methods of treating arthritis, particularly osteoarthritis and inflammatory arthritis, enhancing cartilage formulation, enhancing chondrocyte cell proliferation and glycosaminoglycan production in a mammal with said

This invention relates to compositions extracted from vegetable matter and more particularly to phytochemicals, including saponogenins and saponins, lignans, phenolic acids, catechins and isoflavones, and especially those extracted from a family of plants including soy, flax, tea, and cocoa and

FIELD OF THE INVENTION The present invention relates to the preparation of phenolic derivatives, pharmaceutical and cosmetic compositions comprising such phenolic derivatives, and their use for the beauty of the skin and for treating diseases. BACKGROUND OF THE INVENTION Phenolic Compounds and their